Literature DB >> 2207129

Stopped-flow investigation of antioxidant activity of estrogens in solution.

K Mukai1, K Daifuku, S Yokoyama, M Nakano.   

Abstract

A kinetic study of the reaction between estrogens (female hormone) and substituted phenoxyl radical has been performed, as a model for the reactions of estrogens with lipid peroxyl radical in biological systems. The rates of reaction of estrogens (estrone 1, estradiol 2, 2-methoxyestrone 3, 3-methoxyestrone 4, and 2-hydroxyestrone 5) with substituted phenoxyl radical in benzene have been determined spectrophotometrically, using stopped-flow technique. The second-order rate constants, k2, obtained are 84 M-1.s-1 for 1, 138 M-1.s-1 for 2, 520 M-1.s-1 for 3, less than 10(-4) M-1.s-1 for 4, and 2.6 X 10(5) M-1.s-1 for 5 at 25.0 degrees C. 2-Hydroxyestrone 5 was found to be 2.9-times more active than alpha-tocopherol, which has the highest antioxidant activity among natural tocopherols. The order of magnitude of k2 value (1 less than 2 less than 3 less than alpha-Toc less than 5) is in agreement with that of in vitro tests of their antioxidant activities, as measured by the inhibition of lipid peroxidation. Further, similar measurements have been performed for the reaction between the above estrogens 1-5 and tocopheroxyl 6 in benzene solution. It was found that the estrogens having an OH group at the aromatic ring have an ability to regenerate the tocopheroxyl 6 to tocopherol. Especially, the 2-hydroxyestrone 5 showed about three orders of magnitude higher reactivity than ascorbic acid.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2207129     DOI: 10.1016/0304-4165(90)90099-i

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

1.  Combined oestrogen-progestogen replacement therapy does not inhibit low-density lipoprotein oxidation in postmenopausal women.

Authors:  Y Wen; M C Doyle; L A Norris; M M Sinnott; T Cooke; R F Harrison; J Feely
Journal:  Br J Clin Pharmacol       Date:  1999-03       Impact factor: 4.335

Review 2.  Cellular and molecular basis of estrogen's neuroprotection. Potential relevance for Alzheimer's disease.

Authors:  N C Inestrosa; M P Marzolo; A B Bonnefont
Journal:  Mol Neurobiol       Date:  1998       Impact factor: 5.590

Review 3.  Review of progress in sterol oxidations: 1987-1995.

Authors:  L L Smith
Journal:  Lipids       Date:  1996-05       Impact factor: 1.880

Review 4.  Auditory function and dysfunction: estrogen makes a difference.

Authors:  Amandine Delhez; Philippe Lefebvre; Christel Péqueux; Brigitte Malgrange; Laurence Delacroix
Journal:  Cell Mol Life Sci       Date:  2019-09-14       Impact factor: 9.261

5.  Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study.

Authors:  F E de Leeuw; J C de Groot; E Achten; M Oudkerk; L M Ramos; R Heijboer; A Hofman; J Jolles; J van Gijn; M M Breteler
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-01       Impact factor: 10.154

6.  Who Should Receive Hormone Replacement Therapy?

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1996       Impact factor: 2.300

7.  Serum vitamin E concentration is negatively associated with body mass index change in girls not boys during adolescence.

Authors:  Xiao-Dong Zang; Qing-Hui Hu; Xiao-Xu Liu; Min Da; Zhao-Cong Yang; Ji-Rong Qi; Xu-Ming Mo
Journal:  World J Pediatr       Date:  2021-09-01       Impact factor: 2.764

Review 8.  Estrogen actions on mitochondria--physiological and pathological implications.

Authors:  James W Simpkins; Shao-Hua Yang; Saumyendra N Sarkar; Virginia Pearce
Journal:  Mol Cell Endocrinol       Date:  2008-05-02       Impact factor: 4.102

9.  Supplementation with vitamins E plus C or soy isoflavones in ovariectomized rats: effect on the activities of Na(+), K (+)-ATPase and cholinesterases.

Authors:  Siomara C Monteiro; Cristiane B Mattos; Emilene B S Scherer; Angela T S Wyse
Journal:  Metab Brain Dis       Date:  2007-05-19       Impact factor: 3.584

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.